These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29741961)

  • 1. Some indazoles reduced the activity of human serum paraoxonase 1, an antioxidant enzyme:
    Alım Z; Kılıç D; Demir Y
    Arch Physiol Biochem; 2019 Dec; 125(5):387-395. PubMed ID: 29741961
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of the inhibitory effects and molecular docking of some sulfonamides on human serum paraoxonase 1.
    Alim Z; Kilic D; Koksal Z; Beydemir S; Ozdemir H
    J Biochem Mol Toxicol; 2017 Oct; 31(10):. PubMed ID: 28665493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzenesulfonamide derivatives containing imine and amine groups: Inhibition on human paraoxonase and molecular docking studies.
    Işık M; Beydemir Ş; Demir Y; Durgun M; Türkeş C; Nasır A; Necip A; Akkuş M
    Int J Biol Macromol; 2020 Mar; 146():1111-1123. PubMed ID: 31739032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Docking Studies and Inhibition Properties of Some Antineoplastic Agents against Paraoxonase-I.
    Demir Y; Türkeş C; Beydemir Ş
    Anticancer Agents Med Chem; 2020; 20(7):887-896. PubMed ID: 32067621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiepileptic drugs: Impacts on human serum paraoxonase-1.
    Beydemir Ş; Demir Y
    J Biochem Mol Toxicol; 2017 Jun; 31(6):. PubMed ID: 28032682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of Potential Paraoxonase-I Inhibitors by Kinetic and Molecular Docking Studies: Chemotherapeutic Drugs.
    Türkeş C
    Protein Pept Lett; 2019; 26(6):392-402. PubMed ID: 30819074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some coumarins and benzoxazinones as potent paraoxonase 1 inhibitors.
    Karataş MO; Uslu H; Alıcı B; Gökçe B; Gencer N; Arslan O
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1386-91. PubMed ID: 26887799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Human Serum Paraoxonase-I with Antimycotic Drugs: In Vitro and In Silico Studies.
    Türkeş C; Beydemir Ş
    Appl Biochem Biotechnol; 2020 Jan; 190(1):252-269. PubMed ID: 31342307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of some antibiotics on paraoxonase from human serum in vitro and from mouse serum and liver in vivo.
    Sinan S; Kockar F; Gencer N; Yildirim H; Arslan O
    Biol Pharm Bull; 2006 Aug; 29(8):1559-63. PubMed ID: 16880604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics Used in Patients after Surgery and Effects of Human Serum Paraoxonase-I (PON1) Enzyme Activity.
    Yılmaz A; Dilek E
    Protein Pept Lett; 2019; 26(3):215-220. PubMed ID: 30678610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of human serum paraoxonase-1 with some respiratory drugs.
    Gökçe B; Sarıoğlu N; Gençer N; Arslan O
    J Biochem Mol Toxicol; 2019 Dec; 33(12):e22407. PubMed ID: 31581362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity.
    Avcikurt AS; Sinan S; Kockar F
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):245-9. PubMed ID: 24934243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibition effect of some coumarin compounds on purified human serum paraoxonase 1 (PON1).
    Gokce B; Gencer N; Arslan O; Karatas MO; Alici B
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):534-7. PubMed ID: 25982292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some Anticancer Agents Act on Human Serum Paraoxonase-1 to Reduce Its Activity.
    Alim Z; Beydemir Ş
    Chem Biol Drug Des; 2016 Aug; 88(2):188-96. PubMed ID: 26873069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphenicol and macrolide derived antibiotics inhibit paraoxonase enzyme activity in human serum and human hepatoma cells (HepG2) in vitro.
    Sinan S; Kockar F; Gencer N; Yildirim H; Arslan O
    Biochemistry (Mosc); 2006 Jan; 71(1):46-50. PubMed ID: 16457617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of PON1 from human serum and assessment of enzyme kinetics against metal toxicity.
    Ekinci D; Beydemir S
    Biol Trace Elem Res; 2010 Jun; 135(1-3):112-20. PubMed ID: 19727574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition effects of some sulfonamides on human serum paraoxonase-1 (hPON1).
    Demir Y; Köksal Z
    Pharmacol Rep; 2019 Jun; 71(3):545-549. PubMed ID: 31109643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition effect of some dihydroxy coumarin compounds on purified human serum paraoxonase 1 (PON1).
    Erzengin M; Basaran I; Cakir U; Aybey A; Sinan S
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1540-8. PubMed ID: 22971832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alternative purification method for human serum paraoxonase 1 and its interaction with methidathion.
    Gençer N; Yavuz E
    Arch Physiol Biochem; 2017 Jul; 123(3):159-164. PubMed ID: 28276711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium-based contrast agents:
    Beydemir Ş; Türkeş C; Yalçın A
    Drug Chem Toxicol; 2021 Sep; 44(5):508-517. PubMed ID: 31179770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.